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Abstract  
  
The use of enzymes in organic synthesis offers many advantages over traditional catalysts                                      
including high catalytic turnover, mild reaction conditions, and specificity. The increasing                                
interest in environmentally friendly production of fuels and chemicals has spurred research and                                      
development of effective and versatile biocatalysts either to be used in organic synthesis or in                                            
living systems. Due to the potential for decarboxylases to produce optically pure products under                                         
mild reaction conditions, we have sought to further investigate phenylacrylic acid decarboxylase                                   
1 (PAD1) and ferulic acid decarboxylase (FDC) from Saccharomyces cerevisiae. These enzymes                                   
have been shown to be responsible for the decarboxylation of antimicrobial phenylacrylic acids;;                                      
however, their specific roles in these reactions remain unknown. We have over-­expressed and                                      
purified PAD1 and FDC from E. coli in order to elucidate the function of each enzyme.                                               
Traditional biochemical, kinetic, and mechanistic techniques were employed to characterize                             
these two enzymes. We have shown that PAD1 is a flavo-­protein that utilizes FMN as a cofactor,                                                  
but does not function as a decarboxylase. Instead, PAD1 catalyzes the formation of a novel,                                            
diffusible cofactor required for decarboxylase activity of FDC. Co-­expression of PAD1 and FDC                                      
results in FDC with high cofactor occupancy and ability to decarboxylate a variety of                                         
phenylacrylic acids with a kcat ranging from 1.4 – 4.6 s-­1. In silico experiments were also                                               
performed to supplement in vitro mechanistic studies. We find that a revised mechanism                                      
involving resonance contributions from the para substituents on the benzyl ring and the presence                                         
of a counter-­ion (Mg2+) were necessary for the construction of a reasonable reaction coordinate                                         
diagram for ferulic acid. The decarboxylation of ferulic acid was found to likely proceed under                                            
nucleophilic,  rather  than  cationic,  conditions.  
Chapter  1:  
Introduction  and  Background  
  
Introduction    
Traditional chemical synthesis and energies production has presented numerous problems                             
in our society such as environmental stress, economic concerns, and reliance on quickly                                      
depleting fossil fuel reserves. One of the most prominent methods to solve these problems is the                                               
in vivo production of non-­natural metabolites in microorganisms via a combination of metabolic                                      
engineering, systems biology, and synthetic biology. This process often requires elements of                                   
bioprospecting – identifying enzymes capable of producing metabolites of interest from both                                   
genomic and proteomic databases – and the introduction of heterologous metabolic pathways in                                      
a desired host organism (e.g., Escherichia coli). This method is beneficial as it opens a vast                                               
resource  of  enzymatic  chemistry  capable  of  producing  a  wide  variety  of  valuable  metabolites.     
The use of natural catalysts (i.e., enzymes) for chemical synthesis is not new and has                                            
been a trend in organic chemistry for some time. Biocatalysts have been used for more than one                                                  
hundred years, employed as either whole cells, cell organelles, or isolated enzymes1,2. They                                      
present many advantages over traditional chemical synthesis. First, enzymes are very efficient                                   
catalysts;; typically enzymes increase the rates of chemical reactions which they catalyze by                                      
108-­1012, which can be far above the rates that chemical catalysts are capable of achieving3.                                            
Enzymes are also environmentally friendly because, unlike heavy metals, they are composed of                                      
amino acids and are completely biodegradable. They are also able to act under mild conditions,                                            
typically at biological pH, and a temperature range of 20 – 40 °C. This permits the minimization                                                  
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of undesired side-­reactions (e.g., decomposition, isomerization, racemization) and reduction of                             
the energy burden of traditional synthesis. Enzymes can also catalyze almost every type of                                         
organic reaction, and even some that are not found in the organic synthesis repertoire such as the                                                  
selective  functionalization  of  nonactivated  groups  in  organic  molecules4.    
The repertoire of enzymatic chemistry is only expected to increase due to the large                                         
amount of genomic data that is becoming available. A recent publication described over one                                         
million novel proteins, known only as open reading frames encoded in genomic DNA5. These                                         
proteins will be the design parts of many future biological systems, enabling sustainable                                      
solutions to many of society’s problems. However, enzymatic pathways that often look                                   
promising from preliminary genomic data are poorly understood and, when transferred into a                                      
host organism, do not perform to optimal levels or even fail to function as desired6. Therefore,                                               
detailed biochemical studies of potentially useful enzymatic reactions are highly important when                                   
attempting  the  construction  of  new,  nonnative  metabolic  pathways.    
Enzyme-­catalyzed decarboxylations are one such class of reactions that are becoming                                
increasingly important in both chemical synthesis and fermentation processes. However,                             
decarboxylation reactions are characterized by high-­energy barriers because the transition state                                
involves a buildup of negative charge on the α-­carbon. Nature has therefore evolved                                      
decarboxylases to overcome this high-­energy barrier through the use of cofactors such as                                      
pyridoxal phosphate and thiamin pyrophosphate that serve as electron sinks, and also Lewis                                      
acidic  metal  ions7,8,9.     
Decarboxylases are of interest for their potential use as industrial catalysts in the                                      
synthesis of optically pure intermediates for organic synthesis under mild reaction conditions10.                                   
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They have also been used in microbial fermentation processes to produce short-­chain alcohols                                      
and in the conversion of overexpressed amino acids to chemical feedstocks such as styrene and                                            
acylamide11,12,13. The investigation of decarboxylases is especially relevant to the search for                                   
effective yet sustainable methods for chemical synthesis as many valuable chemicals can be                                      
generated from the phenylpropanoid pathway in higher plants14. Using plants (i.e., biomass) as a                                         
source of cheap chemical feedstocks to produce commodity chemicals is becoming increasingly                                   
desired. Therefore, the extraction of certain chemicals from plant cell cultures15 or from the                                         
waste products of biomass used in bioenergy processes is an important goal in sustainable                                         
chemistry16. Recent research has demonstrated that the production of various phenylpropanoids                                
can also be achieved in engineered microorganisms, making the microbial production of a                                      
variety of phenylpropanoids a realistic possibility17. Combining phenylpropanoid producing                          
strains with strains containing phenylacrylic acid decarboxylation activity could yield many                                
valuable chemicals, including biofuels, monomers, and industrial flavorings. A recent example                                
of particular interest is the use of ferulic acid decarboxylase (FDC) from Saccharomyces                                      
cerevisiae in conjunction with phenylalanine ammonia lyase (PAL) in an engineered E. coli                                      
strain  that  converts  endogenously  produced  phenylalanine  into  styrene18.  
FDC is found in various strains of yeast that detoxify antimicrobial compounds                                   
commonly used as food preservatives and flavorings, such as sorbic acid and cinnamic acid                                         
(phenylacrylic acid), by decarboxylation to yield CO2 and volatile products pentadiene and                                   
styrene19,20 (Scheme 1 A, B). Initial studies into the nature of decarboxylation of phenylacrylic                                         
acids in S. cerevisiae have begun to elucidate the basis for these biosynthetic reactions.                                         
Originally, a genetic study characterized phenylacrylic acid decarboxylase 1 (PAD1) as                                
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conferring cinnamic acid resistance to S. cerevisiae21. PAD1 was cloned into a cinnamic                                      
acid-­sensitive mutant strain of yeast, restoring cinnamic acid resistance and phenylacrylic acid                                   
decarboxylation. However, the product of the pad1 gene was not shown to possess                                      
decarboxylation activity, despite its name. Importantly, Stratford et al. identified the gene                                   
product of pad1 from S. cerevisiae as being responsible for decarboxylation of sorbic acid,                                         
ferulic acid, coumaric acid, and cinnamic acid into their corresponding products, labeling PAD1                                      
as a unique decarboxylase capable of accepting aromatic and aliphatic substrates. This, among                                      
other examples in the literature, confuse the role of PAD1. The contents of this thesis will help                                                  
clarify the role that PAD1 plays in decarboxylating phenylacrylic acids. In a separate study, the                                            
FDC gene was introduced into sake yeast, which lacks the ability to decarboxylate ferulic acid,                                            
allowing the yeast to decarboxylate ferulic acid22. More recently, the nature of the                                      
decarboxylation of phenylacrylic acids has been more fully investigated. It has been shown that                                         
FDC needs the gene product of the pad1 gene from S. cerevisiae for decarboxylation activity20.                                            
However, FDC was not shown to contain decarboxylation activity unambiguously. It was not                                      
shown until recently that both PAD1 and FDC are required for phenylacrylic acid                                      
decarboxylation activity in yeast20. The ability of S. cerevisiae to decarboxylate various                                   
phenylacrylic acids was investigated using fdc, pad1, and fdc/pad1 knockout strains. It was                                      
found that ferulic acid, p-­coumaric acid, and trans-­cinnamic acid could not be decarboxylated                                      
into their respective products without both the pad1 and fdc genes present. However, the nature                                            
of the interaction between PAD1 and FDC has not been evaluated biochemically and the work                                            
described herein identifies how these proteins work cooperatively to achieve decarboxylation                                
activity.    
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Scheme 1: (A and B) Reactions shown to have been catalyzed by PAD1, FDC in yeast and                                                  
recombinant E. coli. (C) Intermediate step in ubiquinone synthesis catalyzed by UbiX, UbiD in                                         
bacteria.    
  
Interestingly, PAD1 and FDC are thought to be homologs of UbiX/UbiD, two enzymes                                      
involved in an intermediate step in the biosynthesis of ubiquinone in a wide range of bacteria.                                               
They catalyze the decarboxylation of the aromatic intermediate 4-­hydroxy-­3-­octaprenylbenzoic                          
acid to 2-­octaprenylphenol23,24 (Scheme 1C). It is important to note that previous literature                                      
confused the roles of UbiD/UbiX as isofunctional24. However, the work described herein                                   
clarifies the interaction between these two enzymes. Crystal structures of related decarboxylases                                   
and sequence comparisons suggest that UbiX and PAD1, and by extension UbiD and FDC, may                                            
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be flavo-­proteins. However, the function of the flavin prosthetic group in these enzymes remains                                         
unknown.    
The nature of this study is to further characterize FDC/PAD1 by elucidating their                                      
structural properties, biochemical properties, and how their interaction brings about the                                
decarboxylation of a range of phenylacrylic acids. Preliminary studies into the mechanism of                                      
decarboxylation by FDC are also presented. As a result of this work, conclusions can also be                                               
made  about  the  role  of  UbiX/UbiD  in  bacterial  ubiquinone  biosynthesis.    
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Background  
It is important to note here that three key experiments illuminating the interaction                                      
between PAD1 and FDC were performed prior to my work on this project. First, after initial                                               
expression and purification of FDC in E. coli BL21 by standard methods, it was noted that after                                                  
dialysis of FDC against buffer (MW cutoff = 3500 Da), decarboxylation of trans-­cinnamic acid                                         
into styrene was nearly undetectable (Figure 1). However, upon addition of BL21 cell lysate,                                         
decarboxylase activity was fully restored. This suggested that a low-­molecular weight cofactor                                   
was needed for FDC decarboxylation activity. In order to confirm this hypothesis, BL21 cell                                         
lysate was similarly dialyzed and upon addition to dialyzed FDC, activity of FDC was almost                                            
undetectable.    
  
Figure  1:  Relative  activities  of  FDC  as  isolated  from  E.  coli  BL21,  dialyzed  FDC,  FDC  in  BL21  
cell  lysate,  dialyzed  FDC  in  dialyzed  BL21.  (Adapted  from  Lin,  et  al.  ACS  Chem.  Bio.  2014)  
  
7  
Due to PAD1’s sequence similarity to UbiX, it was hypothesized that PAD1 might make                                         
a cofactor that is used by FDC. It was thought that UbiX might substitute for PAD1 in cells                                                     
expressing FDC to give decarboxylation activity. Therefore, an E. coli BL21 ΔubiX strain was                                         
created in order to investigate the possible isofunctionality of UbiX and PAD1. This strain                                         
resulted in FDC with no activity and is hence named apo-­FDC. Apo-­FDC was reacted in a                                               
solution containing ΔubiX cell lysate, and no activity was discerned (Figure 2). Alternatively,                                      
when tPAD1 (truncated PAD1 without mitochondrial localization sequence) was added to                                
apo-­FDC, a small amount of decarboxylation activity was restored. This suggests that tPAD1                                      
retains a small amount of the cofactor after its expression and purification and is able to release it                                                     
to FDC. Lastly, when tPAD1 and ΔubiX cell lysate were added to apo-­FDC, decarboxylation                                         
activity  was  greatly  increased.    
  
Figure 2: Specific activities of apo-­FDC, apo-­FDC in ΔubiX cell lysate, apo-­FDC with tPAD1                                         
purified from E. coli BL21 (DE3), apo-­FDC in ΔubiX cell lysate with tPAD1. (Adapted from                                            
Lin,  et  al.  ACS  Chem.  Bio.  2014).  
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In  order  to  definitively  confirm  that  PAD1/UbiX  creates  a  small  cofactor  necessary  for  
FDC  activity,  and  that  PAD1  itself  does  not  participate  directly  in  the  decarboxylation  reaction,  
the  following  experiment  was  performed  (Figure  3).  A  dialysis  chamber  was  set  up  with  FDC  
and  6.7  mM  of  trans-­cinnamic  acid  on  one  side  while  the  other  side  had  either  BL21  cell  lysate,  
ΔubiX  cell  lysate,  or  ΔubiX  cell  lysate  with  tPAD1.  Production  of  styrene  from  trans-­cinnamic  
acid  was  monitored  over  time.  The  results  indicate  that  although  BL21  cell  lysate  and  tPAD1  
were  able  to  restore  some  decarboxylation  activity,  ΔubiX  cell  lysate  with  tPAD1  allowed  
restoration  of  maximal  activity.  This  suggested  that  PAD1  makes  a  diffusible  low-­molecular  
weight  cofactor  from  endogenous  elements  of  E.  coli  that  is  necessary  for  FDC  to  decarboxylate  
phenylacrylic  acids.  It  also  indicates  that  UbiX  makes  the  same  cofactor  necessary  for  activity  of  
FDC.  In  tandem  with  the  information  that  UbiD  and  UbiX  are  necessary  for  the  decarboxylation  
of  4-­hydroxy-­3-­octaprenylbenzoic  acid  to  2-­octaprenylphenol  in  ubiquinone  biosynthesis22,  
UbiD  most  likely  makes  the  same  cofactor  as  PAD1  that  is  required  by  UbiX  to  perform  
decarboxylation  of  the  aromatic  4-­hydroxy-­3-­octaprenylbenzoic  acid.    
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  Figure 4: Direct interaction of tPAD1 and FDC is not required for activation of FDC. FDC in                                                  
buffer containing 6.7 mM cinnamic acid was separated by a 3500 Da cutoff dialysis membrane                                            
from either BL21 cell lysate, ΔubiX cell lysate, or ΔubiX cell lysate with tPAD1. The production                                               
of  styrene  was  monitored  over  time.  (Adapted  from  Lin,  et  al.  ACS  Chem.  Bio.  2014)  
  
  
These experiments demonstrate that UbiX/tPAD1 make a low-­molecular weight,                          
diffusible cofactor that is necessary for FDC to perform decarboxylation. The direct interaction                                      
of tPAD1 and FDC is not required for transfer of this prosthetic group. It is also found that UbiX                                                        
can substitute for tPAD1, however, it is not sufficient in creating highly active FDC, presumably                                            
due to a low occupancy. These experiments were critical in forming the basis for the following                                               
work  in  characterizing  both  FDC,  tPAD1,  and  the  cofactor  necessary  for  activity  of  FDC.    
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Chapter  2:  
Results  and  Discussion  
  
Results  and  Discussion  
Properties  of  recombinantly  expressed  and  purified  FDC    
As mentioned in the background, FDC requires a low-­molecular weight, diffusible                                
cofactor for activity. Therefore, an expression vector containing both the tpad1 gene (tpad1 has                                         
no 6-­his tag and was not purified from this construct) and a 6-­his tagged fdc gene under the                                                     
control of a single T7 promoter was constructed and transformed into E. coli BL21 to create a                                                  
highly  active  FDC.  
The specific activity of FDC expressed as a single gene on the expression vector in                                            
decarboxylating trans-­cinnamic acid to styrene was determined by a GC-­MS assay (see                                   
Materials and Methods section) to be ~31 µM styrene.min-­1.µM-­1 enzyme. However, when FDC                                      
was co-­expressed in a plasmid also containing the tpad1 gene , activity was shown to increase to                                                  
247  µM  styrene.min-­1.µM-­1.enzyme,  a  roughly  8-­fold  increase.  
NATIVE-­PAGE analysis of FDC performed by Fengming Lin indicated that the protein                                   
migrated with an apparent molecular weight of ~ 480 kDa, suggesting that the protein may adopt                                               
an octameric form in solution (Figure 5A). SDS-­PAGE analysis indicates that monomeric FDC                                      
has a weight of ~58 kDa (Figure 4B) . This is in agreement with LC-­ESI-­MS results performed                                                  
by Fengming Lin that demonstrate a monomeric weight of FDC being 57898.15 Da (Figure 5B).                                            
Both results are in excellent agreement with the predicted mass of 57897.8 Da. The activity of                                               
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FDC was found by Fengming Lin to be optimal between pH 7.0 -­ 8.0, declining sharply at pH                                                     
below  7  (Figure    5C).    
  
  
  
  
Figure 4: In order to further investigate the characteristics and mechanism of FDC, 6-­his tagged                                            
FDC was successfully overexpressed and purified using standard methods (A) Typical                                
purification scheme (B) SDS-­PAGE analysis indicative of typical purity of eluted FDC to be                                         
high.  
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  Figure 5: (A) NATIVE-­PAGE analysis of purified FDC. (B) ESI-­MS of purified FDC. (C) pH                                            
dependence  of  cinnamic  acid  decarboxylase  activity.    
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Characterization  of  tPAD1    
Characterization of tPAD1 was carried out via NATIVE-­PAGE and SDS-­PAGE. The                                
genetic characterization of PAD1 indicated that PAD1 consists of 242 amino acid peptide with a                                            
MW of 26743.7 Da21. However, in order to properly purify the protein, a 58 residue leader                                               
sequence believed to encode a mitochondrial targeting sequence was removed, this protein is                                      
hence referred to as tPAD. This leads to a predicted molecular weight of 21806.4 Da.                                            
SDS-­PAGE analysis corroborates the predicted molecular weight of tPAD1 as being ~ 22 kDa                                         
(Figure 6A). Liquid-­chromatography electrospray ionization mass spectrometry (LC-­ESI-­MS)                       
performed by Fengming Lin confirmed the monomeric weight of tPAD1 as being 21808.6 Da                                         
(Figure 6B), in excellent agreement with the predicted molecular weight of 21806.4 Da.                                      
NATIVE-­PAGE analysis indicated that tPAD1 migrated with a molecular weight of ~ 300 kDa,                                         
suggesting that tPAD1 adopts a dodecameric structure in solution (Figure 6A). Gel-­filtration                                   
chromatography performed by Fengming Lin also supports a molecular weight of the native                                      
protein as ~ 300 kDa, suggesting it is a dodecameric protein in solution. A crystallographic study                                               
indicated that a homolog of PAD1 with 54% sequence identity, FMN-­dependent UbiX-­like                                   
decarboxylase Pad1 from Escherichia coli O157:H7, forms a dodacameric structure with                                
individual trimers forming the basic units. Our results indicate that tPAD1 may not only share                                            
sequence  homology  to  this  protein,  but  also  adopt  similar  high  order  quaternary  structures.    
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Figure 6: (A) NATIVE-­PAGE and SDS-­PAGE analysis of purified tPAD1. (B) ESI-­MS analysis                                      
of  purified  tPAD1.  (C)  UV/vis  spectrum  of  holo-­tPAD1    
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Identification  of  FMN  as  cofactor  for  tPAD1  
Purified tPAD1 shows homology to enzymes that utilize FMN as a cofactor27. Purified tPAD1                                         
was also visibly yellow and the UV-­vis spectrum exhibits absorbance peaks at 384 nm and 458                                               
nm (Figure 6C), indicating the presence of oxidized FMN. The presence of FMN as a cofactor                                               
was  confirmed  first  using  reverse-­phase  high  performance  liquid  chromatography  (HPLC).    
  
  
  
Figure 7: (A) HPLC chromatogram of isolated cofactor solution from tPAD1. (B) UV/vis                                      
spectrum  of  putative  cofactor  at  retention  time  =  4.3  min.    
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The enzyme was thermally denatured at 100℃ for 10 min. and the resulting solution was                                               
filtered using an Amicon 3K spin filter to isolate the cofactor. The isolated cofactor was run on                                                  
HPLC (see Methods and Materials for conditions). FAD and FMN standards were also run on                                            
the same conditions for comparison. The retention times of the cofactor was determined to be 4.3                                               
min. (Figure 7A) while the retention times of FMN and FAD were found to be 4.3 min. and 3                                                        
min., respectively. The UV spectrum of the cofactor exhibited maxima at 371 and 446 nm,                                            
indicating  the  presence  of  a  oxidized  flavin  (Figure  7B).    
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  Figure 8: (A) HPLC chromatogram of isolated cofactor solution from purified tPAD1                                   
supplemented  with  5  μM  FMN  .  (B)  UV/vis  spectrum  of  peak  at  retention  time  =  4.3  min.    
  
When the isolated cofactor was spiked with 5 μM FMN, the peak corresponding to the                                            
cofactor grew in size proportional to the amount of FMN added (Figure 8A) while also                                            
maintaining the spectral properties of FMN (Figure 8B). This result strongly suggested that                                      
tPAD1 uses FMN as a cofactor. When supplemented with FAD, the peak corresponding to 4.3                                            
min. did not grow in size and a separate peak at 3 min. appeared with spectral properties of FAD                                                        
(data  not  shown).    
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LC-­ESI-­MS analysis was used to further confirm the identity of the cofactor used by                                         
tPAD1 as being FMN. Purified tPAD1 was denatured and the cofactor isolated as previously                                         
described. The isolated cofactor was then analyzed by LC-­ESI-­MS to determine its molecular                                      
weight.    
  
  
Figure  9:  LC-­ESI-­MS  chromatogram  of  tPAD1  cofactor  confirmed  to  be  FMN.    
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Chromatographic analysis identified a molecule with (m+1)/z of 457.1123 Da matching                                
an authentic standard of FMN, Mr = 456 (Figure 10). These results confirm that tPAD1 utilizes                                               
FMN  as  a  cofactor,  although  it  is  unclear  the  exact  role  that  FMN  plays  in  the  function  of  tPAD1.    
The UV spectrum of purified tPAD1 (Figure 7C) had maxima at 384 nm and 458 nm. However,                                                  
the UV spectrum of tPAD1 also exhibited characteristics of a second chromophore, due to the                                            
fact that the absorbance at 384 nm was stronger than at 458 nm, whereas the opposite is true for                                                        
oxidized FMN. This indicates that tPAD1 may contain another chromophore, although no other                                      
peaks  were  detected  on  LC-­ESI-­MS.    
  
  
  
  
  
  
  
  
  
  
  
  
  
  
20  
Isolation  and  characterization  of  cofactor  from  FDC  
In order to study the properties of the novel flavin-­cofactor, it was necessary to find an                                               
efficient method of enzyme denaturation to obtain highly pure cofactor. Several methods were                                      
explored including thermal denaturation, chaotropic agents such as SDS, and organic solvents                                   
such as acetonitrile. The fastest and most efficient method was determined to be precipitation                                         
with 1:1 solution of methanol and dichloromethane. In typical isolations, the cofactor was                                      
released from holo-­FDC by precipitation with 1:1 methanol:dichloromethane and removed by                                
centrifugation (Figure 10). The organic phase was removed under a stream of N2 and the aqueous                                               
phase  was  typically  filtered  using  a  3K  Amicon  spin  filter  to  remove  any  remaining  protein.    
  
Figure  10:  Cofactor  isolation  scheme.    
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  Figure  11:  (A)  LC-­ESI-­MS  of  possible  breakdown  product  (B)  MW  of  putative  cofactor  
  
The isolated cofactor was analyzed by LC-­ESI-­MS. The resulting chromatogram                             
consistently indicated the presence of several molecules (Figure 11). Most prominently, a                                   
molecule with (m+1)/z of 661.2280 Da was identified on the resulting chromatogram (Figure                                      
11B). Another consistent peak was a molecule with (m+1)/z of 541.1691 (Figure 11A). This                                         
peak is most likely a breakdown product of the peak at ~661 Da, which represents the true                                                  
cofactor. These data, in conjunction with the knowledge that PAD1 uses FMN as a prosthetic                                            
group, suggest that PAD1 makes a covalent modification of FMN to produce the cofactor                                         
necessary  for  activity  of  FDC.    
Fluorescence  of  Isolated  Cofactor  
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The cofactor was isolated from purified FDC as previously described and analyzed using                                      
fluorescence spectroscopy. The isolated cofactor was excited at 345 nm and the emission profile                                         
was observed from 450-­700 nm (Figure 12A). A 50 μM FMN standard was also run under the                                                  
same conditions. The resulting redshift in maximum absorbance suggests that the cofactor is                                      
likely  to  be  a  FMN-­derivative  in  the  reduced  state.    
  
  
Figure  12:  (A)  Fluorescence  emission  spectrum  of  isolated  cofactor.  (B)  Fluorescence  emission  
spectrum  of  50  μM  FMN  standard.  
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Enzyme  Kinetics  Studies  
FDC was characterized using a UV/vis spectroscopic assay to determine its kinetic                                   
properties. The decarboxylation of trans-­cinnamic acid to give styrene was used as an initial                                         
model, although other substrates (e.g., p-­coumaric acid, ferulic acid) have been subsequently                                   
examined. A summary of the observed kinetic parameters is found in Table 1. The disappearance                                            
of trans-­cinnamic acid at 304 nm was used to follow the progress of the reaction. A range of                                                     
substrate concentrations was used to fit reaction velocities to a Michaelis-­Menten curve (Figure                                      
13A) and Lineweaver-­Burke plot (Figure 13B) in order to determine kinetic parameters. The                                      
initial results indicate an observed kcat of 2.5 s
-­1, Km of 232 μM, Vmax of 147.1 μM/min. and                                                     
kcat/Km  of  1.08x10
5  M-­1s-­1.    
  
Figure 13: (A) Michaelis-­Menten curve produced by monitoring initial reaction velocities as a                                      
function of varying cinnamic acid concentration. (B) Corresponding Lineweaver Burke plot of                                   
1/Initial  Velocity  vs.  1/[substrate].    
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Substrate     kcat  (s-­1)   Km  (mM)   kcat/Km  (s-­1  M-­1)  
cinnamic  acid   4.6  ±  0.2   180  ±  24   25500  ±  3500  
ferulic  acid   3.8  ±  0.3   180  ±  41   21000  ±  4500  
p-­coumaric  acid   1.5  ±  0.1   110  ±  26   13600  ±  880    
  
Table  1:  Observed  kinetic  parameters  of  FDC  decarboxylating  a  variety  of  phenylacrylic  acids.    
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Mechanistic  Studies  
Although PAD1 and FDC have been characterized for the first time in terms of their                                            
basic structural and biochemical properties, the reactions which they catalyze have yet to be                                         
understood at a mechanistic level. Efforts to understand the mechanism by which PAD1 creates                                         
the novel FMN-­derived cofactor have been hindered by a low yield and lack of precedence in                                               
flavo-­protein chemistry. Attempts to reconstitute an in vitro system by which PAD1 can create                                         
the cofactor necessary to activate apo-­FDC have thus far produced no results. The addition of                                            
many commonly found and commercially available metabolites such as thiamine pyrophosphate,                                
pyridoxal phosphate, nucleotides, NADH, NADPH, FMN and FAD and various metal ions were                                      
unsuccessful  in  allowing  PAD1  to  activate  apo-­FDC.    
However, the mechanism by which FDC catalyzes the decarboxylation of various                                
phenylacrylic acids has met with more success. Related enzymes have been shown to                                      
decarboxylate phenylacrylic acids and their respective mechanisms have been suggested as the                                   
result of structural data, most notably the decarboxylation of ferulic acid by ferulic acid                                         
decarboxylase from Enterobacter24 (named FADase, not to be confused with FDC from S.                                      
cerevisiae). However, these related enzymes have not been shown to need the same cofactor as                                            
FDC  and  may  proceed  through  significantly  different  intermediates.    
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  Figure (14): 1H-­NMR isotopic exchange experiment demonstrates that the trans-­terminal                             
hydrogen of styrene originates from the solvent. (A) Styrene standard in phosphate buffer                                      
(B) Styrene produced from cinnamic acid in non-­deuterated phosphate buffer. (C) Styrene                                   
produced  from  cinnamic  acid  in  deuterated  HEPES  buffer.    
  
Further studies in our lab have refined the initial kinetic parameters of cinnamic acid                                         
decarboxylation as well as examined a wider range of substrates including p-­coumaric acid and                                         
ferulic acid (Table 1). Preliminary NMR data has also demonstrated that the trans-­terminal                                      
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hydrogen of styrene originates from the solvent stereospecifically upon decarboxylation,                             
suggesting that a protonation of the terminal double bond is a likely first step (Figure 14). Taking                                                  
into account these data along with a review of enzyme-­catalyzed decarboxylations, we believe                                      
two mechanisms are likely to occur, each occurring through a distinct intermediate. The two                                         
possible mechanisms are i) nucleophilic attack on the β-­carbon in conjunction with α-­carbon                                      
protonation followed by subsequent decarboxylation and leaving of the nucleophile or ii)                                   
α-­carbon protonation leading to a carbocation intermediate which then undergoes spontaneous                                
decarboxylation  (Scheme  2).  
  
  
Scheme  2:  Possible  mechanisms  of  polyacrylic  acid  decarboxylation  by  FDC  
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In order to inform mechanistic studies, in silico methods were utilized to identify which                                         
reaction pathway is more likely. We set out to use the computational software Spartan 14 to                                               
determine the energies of the various chemical species along the possible reaction pathways.                                      
Spartan 14 allows quantum calculations using different levels of theory (e.g., semi-­empirical and                                      
ab initio) and basis sets (e.g., AM1, PM3, B3LYP) that account for the electronic structure of                                               
atomic  and  molecular  species  to  varying  degrees  of  accuracy.  
Although much progress has been made in quantum chemistry in the last two decades due                                            
largely to the development of faster and more powerful computers, predicting chemical reactions                                      
remains a non-­trivial matter26. We have found that to be the case here as well. With no structural                                                     
information regarding the active site of FDC, the possible reaction space seems almost infinite.                                         
We have attempted to probe the mechanisms presented in Scheme 2 using both semi-­empirical                                         
and Density Functional Theory (DFT) calculations. Our initial method of action was to use                                         
Spartan 14 to find equilibrium and transition state geometries with the semi-­empirical AM1 level                                         
of theory and then determine subsequent energy profiles with DFT. However, finding reasonable                                      
transition states, especially for the initial protonation step, proved difficult. Due to the large                                         
amount of trial and error, limited computing time, and little progress, a revised mechanism was                                            
constructed that seemed to give reasonable results and insight into the likelihood of the two                                            
possible mechanisms. In particular, both the carbocation and nucleophilic mechanism of the                                   
decarboxylation of ferulic acid were examined using the revised mechanism (Scheme 3).                                   
Energies of starting materials, intermediates, transition states, and final products were examined                                   
using semi-­empirical PM3 level of theory. This basis set was chosen in order to account for the                                                  
added  orbitals  of  magnesium  while  still  being  computationally  feasible.  
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  Scheme  3:  Revised  mechanism  of  decarboxylation  of  ferulic  acid  by  FDC  
  
The revised mechanism proved to give more reasonable energies as predicted by the PM3                                         
level of theory in Spartan 14 and can help us make some basic assumptions about the                                               
nucleophilic vs. carbocation mechanism. First, it was found to be necessary to add a counter-­ion                                            
to the carboxyl group in order for both mechanisms to proceed. Otherwise, our results suggested                                            
that the intermediate would revert back to the starting materials, or an intramolecular proton                                         
transfer would result in the carboxyl group protonated. Therefore, Mg2+ was added in simulations                                         
involving the revised mechanism. Mg2+ was chosen due to the fact that preliminary data suggests                                            
that FDC uses an FMN-­modified cofactor, which often coordinates with a Mg2+ ion for                                         
stabilization of the negatively charged phosphate group. It should be noted however that no other                                            
counter ion was selected, and it would be plausible that a positively charged amino acid side                                               
chain (e.g., arginine) could fulfill this role. Second, the resonance contribution from the                                      
electron-­donating para-­hydroxyl group was found to be necessary for protonation of the double                                      
bond in the first step. Perhaps suggesting that the para-­hydroxyl group may first get                                         
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deprotonated by an amino acid side chain in order to donate its electrons into the pi-­conjugated                                               
system,  as  suggested  in  previous  studies25.    
It should be noted that the first step in the revised nucleophilic mechanism was chosen to                                               
be concerted, having water act as a both a proton source and a nucleophile. It is much more                                                     
likely that there involves more chemical species to perform this reaction (i.e., a separate proton                                            
source and nucleophile);; however, it order to keep energy calculations commensurate between                                   
both both reactions, we chose to use water in both cases. Also, the calculations were performed                                               
in gas phase, and this would presumably differ greatly from the conditions of the enzyme active                                               
site.  However,  the  gas  phase  calculations  serve  as  starting  point  for  future  studies.  
  
  
Figure 15: Reaction coordinate diagram for revised mechanism of ferulic acid decarboxylation.                                   
Reaction progress monitored at SM (starting materials), TS1 (first transition state, INT                                   
(intermediate),  TS2  (second  transition  state),  and  FP  (final  products).    
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It is clear from Figure 15 that the carbocation mechanism includes a lower energy                                         
intermediate, but much higher transition state between the intermediate and the final product.                                      
Contrary to previous assumptions, the intermediates of both mechanisms have very similar                                   
energies. It was thought that the carbocation intermediate would be higher in energy due to the                                               
presence of an open-­shell carbon. However, this was not found to be the case, and it is proposed                                                     
that the resonance stabilization from the para-­hydroxyl contributes to the stability of the                                      
intermediate. Indeed, when examining the electron density maps, it was surprisingly found that                                      
the most positive charge was located on the α-­carbon of the carboxyl group. Presumably, this                                            
signifies the readiness of the intermediate to lose the carboxyl group in order to reform the                                               
double bond between the exocyclic carbon atoms. The energy of the final products indicate that                                            
this reaction is overall exothermic, most likely due to the creation of a stable carbon dioxide                                               
species. The nucleophilic mechanism is much more iso-­energetic relative to the carbocation                                   
mechanism and may represent a more likely mechanism, under these conditions. This was                                      
expected due to the fact that no open-­shell atoms exist in any state of the reaction. Both reaction                                                     
mechanisms  are  exothermic  under  these  conditions.    
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Chapter  3:  
Conclusions  and  Future  Directions  
  
Conclusions  
FDC and PAD1 from S. cerevisae were successfully recombinantly expressed and purified in E.                                         
coli. The results described characterize biochemically the enzymes PAD1 and FDC from S.                                      
cerevisiae for the first time. Importantly, it was found conclusively that PAD1 does not function                                            
as a decarboxylase, despite its name. It was found that PAD1 utilizes a FMN cofactor, most                                               
likely adopts a high order dodecameric structure in solution, and synthesizes a novel cofactor                                         
necessary for activity of FDC. This cofactor is most likely a covalently modified FMN in the                                               
reduced state. Its molecular weight was determined to be ~661 Da by LC-­ESI-­MS. It has been                                               
shown that this cofactor is released to FDC and that direct interaction of PAD1 and FDC are not                                                     
needed for decarboxylation activity. FDC was shown to have optimal activity between pH 7.0                                         
and 8.0, declining sharply at pH less than 7. FDC most likely adopts an oligomeric structure in                                                  
solution. FDC was shown to decarboxylate a variety of phenylacrylic acids with kcat ranging                                         
from ~1.5 -­ 4.6 s-­1. When FDC was expressed without tPAD1 present, the activity was low, but                                                  
still present. When tPAD1 was co-­expressed with FDC, the activity was dramatically increased                                      
by roughly 8-­fold in decarboxylation of cinnamic acid. These data suggest that UbiX can                                         
substitute for tPAD1 in activating FDC, suggesting that the same cofactor is required by UbiD                                            
for  decarboxylation  of  3-­hydroxy-­4-­octaprenylbenzoic  acid  by  UbiD.    
NMR and kinetic experiments continue to elucidate the mechanism of the enzyme                                   
catalyzed decarboxylation. These studies indicate that there are two likely decarboxylation                                
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routes: one with a carbocation intermediate and the other occurring under nucleophilic (basic)                                      
conditions. In order to supplement in vitro experiments with computational studies, in silico                                      
methods were used to elucidate the likelihood of each mechanistic route. We find that a revised                                               
mechanism involving resonance contributions from the para substituents on the benzyl ring and                                      
the presence of a counter-­ion (Mg2+) were necessary for the construction of a reasonable reaction                                            
coordinate diagram for ferulic acid. Under these conditions, it is believed that although both the                                            
carbocation and nucleophilic reaction pathways are found to be exothermic, the nucleophilic                                   
mechanism  is  more  plausible  due  to  lower  energy  transition  states.    
  
Future  Directions  
Our current work is focused on further elucidating the mechanism whereby FDC                                   
decarboxylates phenylacrylic acids. Studies using various substituted phenylacrylic acids to                             
determine new kinetic parameters are being performed to allow the construction of a Hammett                                         
correlation plot. These experiments should help support one of the two possible mechanistic                                      
routes outlined above. In order to increase the activity of FDC, a synthetic operon is being                                               
constructed with the pad1 and fdc genes both under the control of two individual T7 promoters.                                               
This should allow increased levels of PAD1 in E. coli expressing this dual construct.                                         
Correspondingly, increased production of PAD1 should allow for a higher cofactor occupancy of                                      
FDC, which should lead to higher observable kcat. Crystallization of FDC leading to X-­ray                                         
structures would greatly facilitate not only mechanistic studies, but also protein engineering                                   
efforts through the use of active site mutagenesis and perhaps even structure-­guided                                   
recombination.    
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Further computational studies could be performed at higher levels of theory (e.g., DFT)                                      
to obtain more accurate geometries and energies. A great variety of proton sources, nucleophiles,                                         
and counter-­ions could be examined to determine the robustness of the revised mechanism                                      
obtained from preliminary calculations. An X-­ray structure of FDC would also greatly facilitate                                      
enzyme active site modeling such as docking studies for virtual screening of substrates. In                                         
addition, an X-­ray structure would allow amino acid residues to be used in future computational                                            
studies in place of water and magnesium to act as the proton source/counter-­ion. The X-­ray                                            
structure of either PAD1 or FDC with the flavin-­derived cofactor could also help understand                                         
what  role  this  prosthetic  group  plays  in  the  reaction,  if  any.    
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Methods  and  Materials  
Protein  Expression  and  Purification  
Protein expression was performed by standard methods. E. coli cultures were grown at 32℃ in                                               
LB medium supplemented with 50 µg/mL kanamycin to an OD600 of 0.6 ~ 0.8 and gene                                               
expression induced with 0.2 mM isopropyl-­D-­thiogalactopyranoside (IPTG) overnight before                          
harvesting  the  cells  by  centrifugation.    
  
In a typical purification of FDC or PAD1, 7 g (damp weight) of cells were resuspended in 50 mL                                                        
binding buffer (20 mM phosphate buffer, pH 8.0, 500 mM NaCl, 20 mM imidazole, 5% glycerol,                                               
1 mM THP). 0.5 mg/mL of lysozyme, 1 protease inhibitor tablet (Roche), 1 µL of DNAse                                               
(Novagen) and 1 mM tris(hydroxylpropyl) phosphine (THP) were added to the cell suspension                                      
and incubated on ice for 1 h with gentle shaking. The cells were lysed by sonication at                                                  
maximum power using 2 s pulses separated by 8 s to prevent overheating for a total time of 30                                                        
min. The supernatant was separated from cell debris by centrifugation at 15000 g at 4 °C for 30                                                     
min. Protein purification was performed using an ÄKTAexplorer™ chromatography system.                             
The supernatant was loaded onto a HisTrap column (GE Healthcare) and the column was washed                                            
with buffer (20 mM phosphate buffer, pH 8.0, containing 500 mM NaCl, 60 mM imidazole, 5 %                                                  
glycerol,) at a flow rate of 1.0 mL/min. The enzyme was eluted from the column with 500 mM                                                     
imidazole in the same buffer. The resulting fractions were analyzed by SDS-­PAGE on a 15 %                                               
gel. The fractions containing the pure target protein were pooled and passed through PD-­10                                         
column  (GE  Healthcare)  for  desalting  into  PBS  buffer  plus  5%  glycerol.  
GC-­MS  Enzyme  Assay  
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Routine assays of FDC activity were carried out in PBS buffer, pH 8.0, with a total volume of                                                     
500 µL, using cinnamic acid, 6.7 mM, as the substrate;; the concentration of FDC was typically 1                                                  
μM. Assays utilizing PAD1 typically included this enzyme at 10 μM. The assay mixtures were                                            
incubated at 32 °C for varying lengths of time, after which the reaction was quenched and the                                                  
reaction products were extracted by addition of 500 μL ethyl acetate;; samples were vortexed for                                            
15 min and then centrifuged in a microfuge at 12000 rpm for 20 min to separate the organic and                                                        
aqueous  phases.    The  amount  of  styrene  produced  was  determined  by  GC-­MS.  
  
GC-­MS analysis was performed using a Shimadzu QP-­ 2010S GC-­MS instrument equipped with                                      
a quadrupole mass detector and a DB-­5 column (Restek, 30m x 0.25 mm x 0.25 µm). The flow                                                     
rate of the helium carrier gas is constant at 1 mL/min and the inlet temperature was maintained at                                                     
200 °C. The interface temperature was maintained at 250 °C. 10 μL injections of the ethyl                                               
acetate extracted solution were made in splitless mode. Oven temperature was held initially at                                         
40 °C for 3.5 min, gradually increased to 90 °C at 14 °C/min, and then gradually increased from                                                     
90 °C to 315 °C at 20 °C/min and finally maintained at 315 °C for 1 min. Chromatographic data                                                        
were analyzed by GC-­MS PostRun analysis software. Enzymatic conversion of cinnamic acid to                                      
styrene  was  quantified  using  a  calibration  plot  of  styrene  standards  of  known  concentration.  
  
Spectroscopic  enzyme  assay  
For high activity preparations of FDC, i.e. enzyme prepared from E. coli strains co-­expressing                                         
tPAD1, the decarboxylation of substrates could be followed by the decrease in absorbance of the                                            
u.v.-­active substrates. Typical assays were performed in 100 mM potassium phosphate buffer,                                   
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pH 7.0, at room temperature and contained 1 μM FDC. The substrate concentrations ranged                                         
between 0.05 mM and 1.5 mM;; at higher concentrations the absorbance of the substrate became                                            
too high. Decarboxylase activity was followed by monitoring the decrease in absorbance at 304                                         
nm for cinnamic acid;; 334 nm for para-­coumeric acid;; and 344 nm for ferulic acid. Velocity data                                                  
were  fitted  to  the  Michaelis-­Menten  equation  using  OriginTM  software.    
  
LC-­MS  analysis  of  proteins  and  small  molecules  
The molecular weights of proteins and small molecules were determined using an Agilent 6520                                         
LC -­ accurate-­mass Q-­TOF MS system. The protein was passed through a desalting column and                                            
acidified with 0.1% formic acid. 5 ml of the sample was injected onto a Poroshell 300SB-­C8                                               
column equilibrated with 0.1% formic acid and 5% acetonitrile. Proteins were eluted for 5 min                                            
with 95% water: 5% acetonitrile followed by an increasing gradient of acetonitrile to 100% over                                            
7 min at a flow rate of 0.5 mL/min. Eluting proteins were detected at 280 nm. Mass data were                                                        
obtained using intact protein mode and analyzed using Agilent MassHunter Qualitative Analysis                                   
software.  The  raw  data  was  deconvoluted  with  respect  to  maximum  entropy.    
  
For small molecule analysis proteins were precipitated with an equal volume of 1:1                                      
dichloromethane:methanol in glass tubes and removed by centrifugation at 3000 g for 10 min.                                         
The organic solvents was removed under a stream of nitrogen. 20 ml of the sample then was                                                  
injected onto a Zorbax 300SB-­C18 column equilibrated with 0.1% formic acid and 5%                                      
acetonitrile, followed by a 2 min washing with 95% water: 5% acetonitrile. Then the gradient of                                               
acetonitrile was increased to 100% over 10 min at a flow rate of 0.4 mL/min. Mass data were                                                     
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obtained using small molecular mode and analyzed using Agilent MassHunter Qualitative                                
Analysis  software.  
  
Reverse  Phase  HPLC    
For HPLC analysis of isolated cofactor, purified tPAD1 was thermally denatured for 10 min. at                                            
100 °C and filtered using an Amicon Ultra 0.5 mL 3K spin column. 50 μL injections were made                                                     
and eluted for 10 min. at a constant flow rate of 1.0 mL/min in isocratic mode with 75% 5 mM                                                           
NH4(OAc) pH 6.5 and 25% methanol. Eluents were monitored at 260 nm and 450 nm. HPLC                                               
analysis was performed using a Shimadzu LC-­20AT Liquid Chromatograph with a SPD-­M20A                                   
Diode Array Detector equipped with a Vydac 201SP C18 Reversed Phase column (90 Å, 5 μm,                                               
4.6  mm  i.d.  x  250  mm).    
Fluorescence  Characterization  
Cofactor was isolated as previously described and analyzed on a Varian Cory Eclipse                                      
Fluorescence Spectrophotometer. Isolated cofactor was excited at 345 nm using a “high”                                   
photomultiplier effect (PMT) and emission was observed from 450 nm to 700 nm. A 50 μM                                               
FMN standard was excited at 345 nm using a “medium” PMT and emission was observed from                                               
450  nm  to  700  nm.    
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Isotopic  NMR  experiments  
3 mM of cinnamic acid was reacted with 1 μM holo-­FDC in deuterated HEPES (100% D20, 100                                                  
mM HEPES, 100 mM KCl, pH 6.8) for 30 min. at 25 degrees Celsius. Styrene was extracted by                                                     
addition of 500 μL deuterated chloroform. Samples were gently inverted for 2 min. and then                                            
centrifuged at 12000 rpm for 20 min. to separate the organic and aqueous phases. The solution                                               
was dried using Molecular Sieves from Fischer Scientific for 5 min. Resulting precipitate was                                         
analyzed using a Variance 400 MHz 1H-­NMR, and compared to a control experiment using                                         
non-­deuterated  HEPES  buffer.    
  
Computational  Studies  
Spartan 14 was used to predict equilibrium/transition state geometries and their corresponding                                   
energies. Semi-­empirical PM3 level of theory was used to calculate vibrational modes, charge                                      
densities, orbitals, and energies. The models were calculated in gas phase (in vacuo). To insure a                                               
realistic transition state geometry was achieved, curved arrows were input before performing the                                      
calculations. After the calculations had completed, the IR spectra were examined to confirm the                                         
existence of an imaginary vibration frequency representative of the transition state. The                                   
frequency was visualized and compared to expected vibrational motion of the transition state.                                      
Energies were found in the output file of each semi-­empirical geometry calculation and were                                         
given as heat of formations (kJ/mol). These energies were plotted against the each chemical                                         
species  to  give  a  reaction  coordinate  diagram.    
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